BFA
ACOR

BlackRock Fund Advisors’s Acorda Therapeutics ACOR Stock Holding History

BlackRock Fund Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$81M Buy
35,917
+5,224
+17% +$12.4M 0.01% 1361
2016
Q3 		$76.9M Buy
30,693
+2,162
+8% +$6.45M 0.02% 1283
2016
Q2 		$87.3M Buy
28,531
+598
+2% +$1.94M 0.02% 1082
2016
Q1 		$88.7M Buy
27,933
+1,347
+5% +$5.59M 0.02% 1057
2015
Q4 		$136M Buy
26,586
+287
+1% +$1.25M 0.03% 727
2015
Q3 		$83.7M Buy
26,299
+1,080
+4% +$4.19M 0.02% 1043
2015
Q2 		$101M Buy
25,219
+190
+0.8% +$734K 0.02% 988
2015
Q1 		$100M Buy
25,029
+1,535
+7% +$7.03M 0.02% 1006
2014
Q4 		$115M Buy
23,494
+1,823
+8% +$7.82M 0.03% 819
2014
Q3 		$88.1M Sell
21,671
-432
-2% -$1.62M 0.02% 939
2014
Q2 		$89.4M Sell
22,103
-1,187
-5% -$4.84M 0.03% 964
2014
Q1 		$106M Buy
23,290
+521
+2% +$2.11M 0.03% 802
2013
Q4 		$79.8M Buy
22,769
+785
+4% +$3.06M 0.02% 1022
2013
Q3 		$90.2M Buy
21,984
+2,683
+14% +$11.6M 0.03% 839
2013
Q2 		$76.4M Buy
+19,301
New +$79.5M 0.03% 852

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock Fund Advisors's ACOR Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Acorda Therapeutics (ACOR) stake by 17% in Q4 2016, buying an estimated $12.4M and bringing the position to 35,917 shares worth $81M. The position accounts for 0.01% of the portfolio, ranked #1361.

BlackRock Fund Advisors first reported a position in ACOR in Q2 2013 and has held it in 15 quarters since. The position peaked at $136M in Q4 2015. 175 funds tracked by Wall St. Rank hold ACOR as of Q4 2016.

  • BlackRock Fund Advisors held 35,917 shares of Acorda Therapeutics worth $81M as of Q4 2016.
  • BlackRock Fund Advisors bought 5,224 Acorda Therapeutics shares in Q4 2016, an estimated $12.4M.
  • Acorda Therapeutics made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1361 holding.
  • BlackRock Fund Advisors first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Acorda Therapeutics position peaked at $136M in Q4 2015.
  • 175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.